Chopra I J
Department of Medicine, UCLA Center for the Health Sciences, Los Angeles, California 90095, USA.
Thyroid. 1998 Mar;8(3):249-57. doi: 10.1089/thy.1998.8.249.
We have devised a practical, sensitive and specific method for simultaneous measurement of free thyroxine (FT4) and free triiodothyronine (FT3) in undiluted serum by direct equilibrium dialysis radioimmunoassay (RIA). Two hundred microliters serum sample was dialyzed against buffer (pH 7.4) for 20 hours at 37 degrees C and approximately 800 microL of the dialysate was used for measuring FT4 and FT3 simultaneously. The assay was set up in polystyrene tubes coated with anti-T4 antibody and available commercially for FT4 measurement (Quest-Nichols Institute, San Juan Capistrano, CA). The mean +/- SE (range) FT4 concentration (ng/dL) was 1.2 +/- 0.04 (0.7.0 to 2.30) in 54 normal subjects. It was significantly increased (3.6 +/- 0.4 [1.8 to 9.6], n = 20) in hyperthyroidism and clearly decreased (0.40 +/- 0.04 [1.10 to 0.70], n = 26] in hypothyroidism. All nonthyroid illness (NTI) patients had normal FT4 except 3, 2 of whom were on amiodarone and 1 had received heparin. Serum FT4 concentration was minimally elevated in 18 newborn cord blood serum (1.40 +/- 0.08 [0.90 to 2.2], cf. normal p < .05). The mean serum FT3 concentration (pg/dL) was 285 +/- 10 (134 to 454) in 54 normal sera. It was clearly increased in hyperthyroidism (1033 +/- 98 [593 to 2134], n = 20, p < .001). However, serum FT3 varied widely in hypothyroidism (27 to 597, mean 235 +/- 24, NS) as did serum total T3 (19 to 175). Interestingly, however, the mean serum FT3 concentration was normal (273 +/- 28 [62 to 575, NS]) in 25 NTI patients. All of these patients had low serum total T3 (46 +/- 5.0 [10 to 84], ng/dL; normal 84 to 160, p < 0.001), while FT3 was clearly normal in 21 of 25 patients and low in the remaining 4 patients. Similarly, among 18 newborn cord blood sera serum FT3 concentration was normal in 15 and subnormal only in the remaining 3 while all had clearly subnormal total T3 (28 to 74 ng/dL).
(1) A practical, sensitive, and specific assay for simultaneous measurement of FT4 and FT3 is described; (2) FT3 is consistently elevated in hyperthyroidism while FT4 is elevated in most (approximately 85%) cases; (3) FT4 is consistently decreased in hypothyroidism but FT3 varies widely; (4). Serum FT3 concentration is normal in approximately 83% of patients with the low T3 syndrome in NTI and newborn cord blood serum. These data suggest that normal FT3 may explain clinical euthyroidism in many patients with the low T3 syndrome.
我们设计了一种实用、灵敏且特异的方法,通过直接平衡透析放射免疫分析法(RIA)同时测定未稀释血清中的游离甲状腺素(FT4)和游离三碘甲状腺原氨酸(FT3)。将200微升血清样本在37℃下与缓冲液(pH 7.4)透析20小时,约800微升透析液用于同时测定FT4和FT3。该测定在涂有抗T4抗体的聚苯乙烯管中进行,可从商业渠道获得用于FT4测定(Quest - Nichols Institute,加利福尼亚州圣胡安卡皮斯特拉诺)。54名正常受试者的FT4平均浓度(ng/dL)为1.2±0.04(0.70至2.30)。甲状腺功能亢进时显著升高(3.6±0.4 [1.8至9.6],n = 20),甲状腺功能减退时明显降低(0.40±0.04 [1.10至0.70],n = 26)。所有非甲状腺疾病(NTI)患者除3例外FT4均正常,其中2例服用胺碘酮,1例接受过肝素治疗。18例新生儿脐血血清中FT4浓度轻度升高(1.40±0.08 [0.90至2.2],与正常相比p <.05)。54份正常血清中FT3平均浓度(pg/dL)为285±10(134至454)。甲状腺功能亢进时明显升高(1033±98 [593至2134],n = 20,p <.001)。然而,甲状腺功能减退时血清FT3变化范围很大(27至597,平均235±24,无显著性差异),血清总T3也是如此(19至175)。有趣的是,25例NTI患者的血清FT3平均浓度正常(273±28 [62至575,无显著性差异])。所有这些患者血清总T3均低(46±5.0 [10至84],ng/dL;正常为84至160,p < 0.001),而25例患者中有21例FT3明显正常,其余4例较低。同样,在18例新生儿脐血血清中,15例FT3浓度正常,仅其余3例低于正常,而所有病例总T3均明显低于正常(28至74 ng/dL)。
(1)描述了一种实用、灵敏且特异的同时测定FT4和FT3的方法;(2)甲状腺功能亢进时FT3持续升高,而FT4在大多数(约85%)病例中升高;(3)甲状腺功能减退时FT4持续降低,但FT3变化范围很大;(4)NTI和新生儿脐血血清中约83%的低T3综合征患者血清FT3浓度正常。这些数据表明,正常的FT3可能解释许多低T3综合征患者的临床甲状腺功能正常状态。